Logo image of RUN

SUNRUN INC (RUN) Stock Fundamental Analysis

NASDAQ:RUN - Nasdaq - US86771W1053 - Common Stock - Currency: USD

6.88  +0.17 (+2.53%)

After market: 6.88 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RUN. RUN was compared to 95 industry peers in the Electrical Equipment industry. RUN may be in some trouble as it scores bad on both profitability and health. RUN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RUN had positive earnings in the past year.
In the past year RUN has reported a negative cash flow from operations.
In the past 5 years RUN reported 4 times negative net income.
RUN had a negative operating cash flow in each of the past 5 years.
RUN Yearly Net Income VS EBIT VS OCF VS FCFRUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

RUN has a Return On Assets (-13.29%) which is in line with its industry peers.
RUN has a worse Return On Equity (-103.55%) than 63.16% of its industry peers.
Industry RankSector Rank
ROA -13.29%
ROE -103.55%
ROIC N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
RUN Yearly ROA, ROE, ROICRUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

The Gross Margin of RUN (18.95%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of RUN has declined.
The Profit Margin and Operating Margin are not available for RUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
RUN Yearly Profit, Operating, Gross MarginsRUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

RUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RUN has been increased compared to 1 year ago.
The number of shares outstanding for RUN has been increased compared to 5 years ago.
RUN has a worse debt/assets ratio than last year.
RUN Yearly Shares OutstandingRUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
RUN Yearly Total Debt VS Total AssetsRUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of -0.19, we must say that RUN is in the distress zone and has some risk of bankruptcy.
RUN has a Altman-Z score (-0.19) which is in line with its industry peers.
RUN has a Debt/Equity ratio of 5.11. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 5.11, RUN is not doing good in the industry: 78.95% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 5.11
Debt/FCF N/A
Altman-Z -0.19
ROIC/WACCN/A
WACC4.55%
RUN Yearly LT Debt VS Equity VS FCFRUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 1.32 indicates that RUN should not have too much problems paying its short term obligations.
RUN has a Current ratio of 1.32. This is in the lower half of the industry: RUN underperforms 66.32% of its industry peers.
A Quick Ratio of 0.99 indicates that RUN may have some problems paying its short term obligations.
With a Quick ratio value of 0.99, RUN perfoms like the industry average, outperforming 44.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.99
RUN Yearly Current Assets VS Current LiabilitesRUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 126.84% over the past year.
RUN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.86% yearly.
Looking at the last year, RUN shows a decrease in Revenue. The Revenue has decreased by -2.09% in the last year.
RUN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.87% yearly.
EPS 1Y (TTM)126.84%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%150%
Revenue 1Y (TTM)-2.09%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%10.06%

3.2 Future

The Earnings Per Share is expected to grow by 5.36% on average over the next years.
The Revenue is expected to grow by 11.47% on average over the next years. This is quite good.
EPS Next Y-168.11%
EPS Next 2Y-73.22%
EPS Next 3Y-49.6%
EPS Next 5Y5.36%
Revenue Next Year9.08%
Revenue Next 2Y10.79%
Revenue Next 3Y11.89%
Revenue Next 5Y11.47%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RUN Yearly Revenue VS EstimatesRUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
RUN Yearly EPS VS EstimatesRUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4 -6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 3.84, the valuation of RUN can be described as very cheap.
Based on the Price/Earnings ratio, RUN is valued cheaper than 97.89% of the companies in the same industry.
RUN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.82.
The Forward Price/Earnings Ratio is negative for RUN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 3.84
Fwd PE N/A
RUN Price Earnings VS Forward Price EarningsRUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

62.11% of the companies in the same industry are more expensive than RUN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 107.59
RUN Per share dataRUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

A cheap valuation may be justified as RUN's earnings are expected to decrease with -49.60% in the coming years.
PEG (NY)N/A
PEG (5Y)0.09
EPS Next 2Y-73.22%
EPS Next 3Y-49.6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RUN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNRUN INC

NASDAQ:RUN (5/23/2025, 8:54:01 PM)

After market: 6.88 0 (0%)

6.88

+0.17 (+2.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners112.59%
Inst Owner Change-1.8%
Ins Owners2.24%
Ins Owner Change3.74%
Market Cap1.57B
Analysts70.67
Price Target12.46 (81.1%)
Short Float %29.95%
Short Ratio4.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)401.85%
Min EPS beat(2)157.13%
Max EPS beat(2)646.57%
EPS beat(4)3
Avg EPS beat(4)228.21%
Min EPS beat(4)-157.51%
Max EPS beat(4)646.57%
EPS beat(8)5
Avg EPS beat(8)-195.6%
EPS beat(12)8
Avg EPS beat(12)-77.27%
EPS beat(16)9
Avg EPS beat(16)-56.48%
Revenue beat(2)1
Avg Revenue beat(2)-0.71%
Min Revenue beat(2)-4.56%
Max Revenue beat(2)3.14%
Revenue beat(4)2
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-5.73%
Max Revenue beat(4)3.14%
Revenue beat(8)2
Avg Revenue beat(8)-3.07%
Revenue beat(12)6
Avg Revenue beat(12)1.46%
Revenue beat(16)10
Avg Revenue beat(16)3.65%
PT rev (1m)-11.52%
PT rev (3m)-28.38%
EPS NQ rev (1m)42.67%
EPS NQ rev (3m)47.91%
EPS NY rev (1m)40.28%
EPS NY rev (3m)-4.89%
Revenue NQ rev (1m)1.39%
Revenue NQ rev (3m)-3.7%
Revenue NY rev (1m)1.8%
Revenue NY rev (3m)-3.26%
Valuation
Industry RankSector Rank
PE 3.84
Fwd PE N/A
P/S 0.75
P/FCF N/A
P/OCF N/A
P/B 0.6
P/tB 0.6
EV/EBITDA 107.59
EPS(TTM)1.79
EY26.02%
EPS(NY)-1.19
Fwd EYN/A
FCF(TTM)-15.51
FCFYN/A
OCF(TTM)-3.18
OCFYN/A
SpS9.12
BVpS11.45
TBVpS11.45
PEG (NY)N/A
PEG (5Y)0.09
Profitability
Industry RankSector Rank
ROA -13.29%
ROE -103.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.95%
FCFM N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
F-Score4
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 5.11
Debt/FCF N/A
Debt/EBITDA 98.7
Cap/Depr 440%
Cap/Sales 135.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.99
Altman-Z -0.19
F-Score4
WACC4.55%
ROIC/WACCN/A
Cap/Depr(3y)457.15%
Cap/Depr(5y)441.02%
Cap/Sales(3y)111.53%
Cap/Sales(5y)108.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.84%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%150%
EPS Next Y-168.11%
EPS Next 2Y-73.22%
EPS Next 3Y-49.6%
EPS Next 5Y5.36%
Revenue 1Y (TTM)-2.09%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%10.06%
Revenue Next Year9.08%
Revenue Next 2Y10.79%
Revenue Next 3Y11.89%
Revenue Next 5Y11.47%
EBIT growth 1Y34.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year144.91%
EBIT Next 3Y42.39%
EBIT Next 5Y26.41%
FCF growth 1Y-13.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.51%
OCF growth 3YN/A
OCF growth 5YN/A